SPINAL METASTASES IN THE MOST COMMON CANCERS

Authors

  • Ruxandra VATAVU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • S. SELARU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Anca SAVA ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Ana Maria DUMITRESCU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Gabriela Florenta DUMITRESCU “Prof. Dr. N. Oblu” Emergency Clinical Hospital, Iasi, Romania
  • B. COSTACHESCU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • C. I. STAN ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • L. EVA “Prof. Dr. N. Oblu” Emergency Clinical Hospital, Iasi, Romania
  • Andreia MEREUTA “Sf. Spiridon” County Clinical Emergency Hospital Iasi, Romania
  • Ana NEMTOI ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Ioana Sadiye SCRIPCARIU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Diana TATARCIUC ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • D. A. CHIRAN ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • A. KNIELING ‟Grigore Popa” University of Medicine and Pharmacy Iași

DOI:

https://doi.org/10.22551/79nf6y53

Abstract

The aims of this study are to identify the underlying causes of spinal injuries and the molecular subtypes which are involved in the production of these pathologies. Materials and methods: This study is a retrospective one, which covered a period of four months (from January 1st to April 30th, 2015), and involved a total of 50 patients who were diagnosed with non-traumatic spinal cord injuries. These patients received treatment at the “Prof. Dr. N. Oblu” Emergency Clinical Hospital in Iași. Results: Despite having a group of just 50 patients we also managed to identify several key factors implicated in bone dissemination of the primary tumor: skeletal homotropism, vertebral bone composition, genetic and epigenetic alterations, bone remodeling imbalance. Conclusions: The study highlights the need for a multidisciplinary approach to manage spinal metastases effectively. The interplay between cancer progression, bone health, and patient’s quality of life, can help healthcare providers to develop more comprehensive management strategies for individuals affected by metastatic disease.

Author Biographies

  • Ruxandra VATAVU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Doctoral School
    Faculty of Medicine

  • S. SELARU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Doctoral School

  • Anca SAVA, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    “Prof. Dr. N. Oblu” Emergency Clinical Hospital, Iasi, Romania

  • Ana Maria DUMITRESCU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Doctoral School

  • B. COSTACHESCU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    “Prof. Dr. N. Oblu” Emergency Clinical Hospital, Iasi, Romania

  • C. I. STAN, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine

  • Ana NEMTOI, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Dental Medicine

  • Ioana Sadiye SCRIPCARIU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine

  • Diana TATARCIUC, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine

  • D. A. CHIRAN, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine

  • A. KNIELING, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Institute of Forensic Medicine

References

1. Patel A. Benign vs malignant tumors. JAMA Oncol 2020; 6(9): 1488.

2. Şelaru Ş, Sava A, Scripcariu DV, et al. Epidemiological and pathological characteristics of spinal metastases from gastrointestinal cancers: a series of 40 cases. Rom J Morphol Embryol 2023; 64(2): 225-234 / doi: 10.47162/RJME.64.2.13.

3. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014 / doi: 10.1002/ijc.29210.

4. Litak J, Czyżewski W, Szymoniuk M, et al. Biological and clinical aspects of metastatic spinal tumors. Cancers (Basel) 2022; 14(19): 4599 / doi: 10.3390/cancers14194599.

5. Ziu E, Viswanathan VK, Mesfin FB. Spinal metastasis. In: StatPearls (Internet). StatPearls Publishing; Treasure Island, FL, USA; 2023.

6. Wewel JT, O’Toole JE. Epidemiology of spinal cord and column tumors. Neurooncol Pract. 2020; 7-9 / doi: 10.1093/nop/npaa046.

7. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev 2016; 25: 16-27 / doi: 10.1158/1055-9965.Epi-15-0578.

8. Wang X, Romero-Gutierrez CW, Kothari J, Shafer A, Li Y, Christiani DC. Prediagnosis smoking cessation and overall survival among patients with non-small cell lung cancer. JAMA Netw Open 2023; 6(5) / doi: 10.1001/jamanetworkopen.2023.11966.

9. Khalil A, Abd El Rahman A, Rahman EA. Place de l’IRM dans le cancer bronchopulmonaire. J Radiol Diagn Interv 2016; 97(4): 411-424.

10. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12(20): 6243s-6249s / doi: 10.1158/1078-0432.CCR-06-0931.

11. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350(16): 1655-1664 / doi: 10.1056/NEJMra030831.

12. Fisher JL, Brown SA, Sorkin JD. Osteoclasts and osteoblasts in bone metastasis. Bone 2006; 38(3): 363-372 / doi: 10.1016/j.bone.2005.09.024.

13. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2(8): 584-593 / doi: 10.1038/nrc867.

14. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31(5): 578-583 / doi: 10.1053/ hp. 2000.6698.

15. Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol 2005; 23(9): 2028-2037 / doi: 10.1200/ JCO.2005.00.991.

16. Sundaresan N, Digiacinto GV, Hughes JE, Cafferty M. Treatment of neoplastic spinal cord compres-sion: results of a prospective study. Neurosurgery 1991; 29(5): 645-650 / doi: 10.1227/00006123-199111000-00003.

17. Kwon ED, Drake CG, Scher HI, et al. Future directions in the treatment of prostate cancer. Mayo Clin Proc 2011; 86(10): 1031-1042 / doi: 10.4065/mcp.2011.0148.

18. Engelhard HH, Villano JL, Porter KR, et al. Clinical presentation, histology, and treatment of intradural spinal cord tumors: The University of Illinois at Chicago experience. Neurosurgery 2010; 67(2): 422-429 / doi: 10.1227/01. NEU.0000371988.73584.97.

19. Guisse TA, Mohammad KS, Clines G, et al. Basic mechanisms responsible for osteolytic and osteo-blastic bone metastases. Clin Cancer Res 2006; 12: 6213s-6216s.

20. Iowa S, Shimo T, Ibaragi S, et al. PTHrP regulates angiogenesis and bone resorption via VEGF ex-pression. Anticancer Res 2010; 30(7): 2755-2767.

21. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastases to bone. Cancer Cell 2003; 3: 537-549.

22. Henderson MA, Danks JA, Slavin JL, et al. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 2006; 66: 2250-2256.

Additional Files

Published

2025-04-07